May 16th – Michael Rezak, M.D., Ph.D.

Understanding Treatment Options and the Latest Research

This special presentation by Dr. Rezak is made possible by the generous support of Teva Pharmaceuticals.

Dr. Michael Rezak, a neurologist and Movement Disorders specialist, serves as the Medical Director of the Parkinson’s Disease Research Society. He also serves as the Medical Director of the APDA Midwest Information and Referral Center and National Young Onset Center. He practices exclusively at the Neurosciences Institute of Central DuPage Hospital where he heads the Movement Disorders Center and the Movement Disorders Functional Neurosurgery Program.

dr-michael-rezak-photo

Dr. Michael Rezak

Dr. Rezak received his Ph.D. in neuroanatomy from the University of Illinois Medical Center in Chicago and his Medical Degree from Loyola University, Stritch School of Medicine. He completed his neurological training at Yale University School of Medicine and has been board certified in Neurology since 1990.

Dr. Rezak is a member of the Scientific Advisory Board of the Chicago Chapter of the Dystonia Medical Research Association and is on the faculty of Activa University (Medtronic Deep Brain Stimulation). He is active in research in Parkinson’s disease (PD) and currently serves as Principal Investigator in several trials, including evaluating new formulations of botulinum toxin formulations; the development of valid markers and risk factors to identify patients in the preclinical phase of PD (funded by the Parkinson’s Disease Research Society); and has been involved in the NIH-funded CORE PD Consortium on Risk for Early Onset Parkinson’s Disease and the Parkinson’s Disease Collaborative Study of Genetic Linkage (PROGENT) studies.

There are currently several clinical trials in Parkinson’s disease underway at Central DuPage Hospital. His work has been published in such journals as Archives of NeurologyMovement Disorders, and Brain Research; and in books including Young Parkinson’s Handbook: A Guide for Patients and Families, published by the American Parkinson Disease Association and the Complete Medical Encyclopedia (Random House).

Lunch will also be provided by Teva Pharmaceuticals.